2026-W46 · Nov 9–Nov 15 · Company · Profile · published
Zimmer Biomet Holdings, Inc. company profile · business segments · history · financial snapshot · S&P 500 rank #416 · 捷邁邦美公司業務歷史財務與標普500地位
SNAPSHOT
| Ticker | ZBH |
| Company | Zimmer Biomet Holdings, Inc. |
| GICS sector / industry | Health Care (XLV) / Health Care Equipment |
| S&P 500 rank (by weight) | #416 · 0.03% (Nov 4, 2026) |
| Sector rank | #49 of 60 in Health Care (Nov 4, 2026) |
| Headquarters | Warsaw, Indiana |
| Founded | 1927 |
| CEO | Ivan Tornos (Chairman, President and CEO) |
| Employees | ~17,000 (as of December 31, 2025) |
| Market cap | $18.51B (Nov 4, 2026) |
| SEC filings | EDGAR — CIK 0001136869 |
WHAT IT DOES
Zimmer Biomet Holdings, Inc. is a global medical technology company designing, manufacturing and marketing orthopaedic reconstructive products, sports medicine, extremities, trauma and surgical products, headquartered in Warsaw, Indiana. Its implants and instruments help surgeons replace damaged knees, hips, shoulders and other joints.
Its one-line model: sell high-value implants and the instruments and technology that go with them into hospital procedures, and grow with ageing populations and rising procedure volumes. Fiscal 2025 net sales were $8.23B, with operating profit of $1.10B and net earnings attributable to Zimmer Biomet of $705.1M.
The moat is surgeon adoption and installed technology: surgeons train on specific systems, hospitals standardise around them, and robotics and data tools deepen the relationship. Growth comes from robotics, the Paragon 28 foot-and-ankle franchise, and international markets.
BUSINESS SEGMENTS
| Americas | The largest geographic market, covering the United States and Latin America orthopaedic sales. |
| Europe, Middle East and Africa (EMEA) | Europe, the Middle East and Africa orthopaedic sales. |
| Asia Pacific | Asia Pacific orthopaedic sales. |
HISTORY
| Year | Milestone |
|---|---|
| 1927 | Justin O. Zimmer founds Zimmer Manufacturing Company in Warsaw, Indiana, initially making aluminium splints. |
| 2001 | Zimmer is spun off from Bristol-Myers Squibb (August 6, 2001) and begins NYSE trading as ZMH. |
| 2015 | Acquisition of Biomet Inc. completes (June 24, 2015), forming Zimmer Biomet Holdings; ticker changes to ZBH. |
| 2025 | Acquires Paragon 28, Inc. (foot and ankle), completed April 21, 2025, for approximately $1.1B. |
| 2025 | Agrees to acquire Monogram Technologies (AI-driven orthopaedic robotics, ~$177M); completed October 7, 2025. |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT
| Total revenue | $8.23B (FY2025 revenue) |
| Operating income | $1.10B (FY2025 operating income) |
| Net income | $705.1M (FY2025 net income) |
| Diluted EPS | $3.55 (FY2025 diluted EPS) |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
Zimmer Biomet is a small-weight health care constituent: rank #416 by weight at 0.03% as of Nov 4, 2026, and #49 in Health Care. As one of the largest orthopaedic implant makers, it is a direct read on elective procedure volumes and the ageing-driven demand for joint replacement.
SOURCES & METHODOLOGY
| Financials, segments, headquarters | Zimmer Biomet Holdings fiscal 2025 Form 10-K via SEC EDGAR and Q4 2025 earnings release (see Financial Snapshot note); headquarters, CEO and history via the Form 10-K and Wikipedia company profile |
| Index weight & ranks | Slickcharts S&P 500 weights, fetched Nov 4, 2026; sector membership per Wikipedia List of S&P 500 companies (GICS) |
| Market cap | $18.51B (Slickcharts, Nov 4, 2026) |
| Logo | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. |
| Chart | SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 股票代號 | ZBH |
| 公司 | Zimmer Biomet Holdings, Inc.(捷邁邦美) |
| GICS 板塊/行業 | 健康護理(XLV)/醫療設備 |
| 標普500排名(按權重) | #416 · 0.03%(Nov 4, 2026) |
| 板塊內排名 | 健康護理板塊 #49(共 60 家)(Nov 4, 2026) |
| 總部 | 美國印第安納州華沙 |
| 成立 | 1927年 |
| 執行長 | Ivan Tornos(董事長、總裁兼執行長) |
| 員工 | 約17,000人(截至2025年12月31日) |
| 市值 | $18.51B(Nov 4, 2026) |
| SEC 申報 | EDGAR — CIK 0001136869 |
業務概覽
Zimmer Biomet Holdings, Inc. 是全球醫療科技公司,設計、製造與銷售骨科重建產品、運動醫學、四肢、創傷及外科產品,總部位於印第安納州華沙。植入物與器械協助外科醫生置換受損的膝、髖、肩及其他關節。
其一句話商業模式是:向醫院手術銷售高價值植入物及配套器械與技術,並隨人口老化與手術量上升而增長。2025 財年淨銷售 82.32 億美元,營業利潤 10.98 億美元,歸屬 Zimmer Biomet 淨利潤 7.05 億美元。
護城河是外科醫生採用與已安裝技術:外科醫生接受特定系統培訓,醫院圍繞系統標準化,機械人與數據工具加深關係。增長來自機械人、Paragon 28 足踝業務與國際市場。
業務板塊
| 美洲 | 最大的地區市場,涵蓋美國與拉丁美洲骨科銷售。 |
| 歐洲、中東及非洲 | 歐洲、中東與非洲骨科銷售。 |
| 亞太 | 亞太地區骨科銷售。 |
歷史
| 年份 | 里程碑 |
|---|---|
| 1927 | Justin O. Zimmer 在印第安納州華沙創立 Zimmer Manufacturing Company,初期生產鋁製夾板。 |
| 2001 | Zimmer 自 Bristol-Myers Squibb 分拆(2001 年 8 月 6 日),以 ZMH 在紐約證券交易所開始交易。 |
| 2015 | 收購 Biomet Inc. 完成(2015 年 6 月 24 日),組成 Zimmer Biomet Holdings;股票代號改為 ZBH。 |
| 2025 | 收購 Paragon 28, Inc.(足踝業務),2025 年 4 月 21 日完成,約 11 億美元。 |
| 2025 | 同意收購 Monogram Technologies(人工智能驅動骨科機械人,約 1.77 億美元);2025 年 10 月 7 日完成。 |
競爭地位
財務快照
| 總收入 | 82.32 億美元(2025 財年收入) |
| 營業利潤 | 10.98 億美元(2025 財年營業利潤) |
| 淨利潤 | 7.05 億美元(2025 財年淨利潤) |
| 稀釋 EPS | 3.55 美元(2025 財年稀釋 EPS) |
主要風險
對標普500的重要性
Zimmer Biomet 是權重較小的健康護理成分股:按權重排名 #416,權重 0.03%(以 2026 年 11 月 4 日為準),健康護理板塊內排名 #49。作為最大的骨科植入物製造商之一,它是擇期手術量與老化驅動的關節置換需求的直接指標。
來源與方法
| 財務、板塊、總部 | Zimmer Biomet Holdings 2025 財年 Form 10-K 數據,經 SEC EDGAR 及 2025 年第四季業績公佈(見財務快照附註);總部、執行長與歷史經 Form 10-K 及維基百科公司資料 |
| 指數權重與排名 | Slickcharts 標普 500 權重,Nov 4, 2026 抓取;板塊歸屬按維基百科標普 500 成分股名單(GICS) |
| 市值 | $18.51B(Slickcharts,Nov 4, 2026) |
| Logo | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。 |
| 股價圖 | SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月線(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-11-04 02:18 · updated 2026-11-15 00:19 · rev 6